Akers Biosciences Inc logo

AKR - Akers Biosciences Inc Share Price

57.5p 0.0  0.0%

Last Trade - 28/03/19

Sector
Healthcare
Size
Micro Cap
Market Cap £11.0m
Enterprise Value £5.12m
Revenue £1.05m
Position in Universe th / 1817
Bullish
Bearish
Unlock AKR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Akers Biosciences Inc revenues decreased 41% to $364K. Net loss increased from $917K to $3.5M. Revenues reflect Particle ImmunoFiltration Assay (“PIFA”) segment decrease of 38% to $354K, MicroParticle Catalyzed Biosensor (“MPC”) segment decrease from $23K to $0K. Higher net loss reflects Administrative Expenses - Balancing valu increase of 13% to $874K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AKR Revenue Unlock AKR Revenue

Net Income

AKR Net Income Unlock AKR Revenue

Normalised EPS

AKR Normalised EPS Unlock AKR Revenue

PE Ratio Range

AKR PE Ratio Range Unlock AKR Revenue

Dividend Yield Range

AKR Dividend Yield Range Unlock AKR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AKR EPS Forecasts Unlock AKR Revenue
Profile Summary

Akers Biosciences, Inc. develops, manufactures, and supplies point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician. The Company’s product offerings focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including diagnostic rapid manual point-of-care tests for the detection of allergic reactions to Heparin and for on- and off-the-job alcohol safety initiatives. The Company's primary focus is on the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated March 9, 1989
Public Since July 24, 2008
No. of Shareholders: 698
No. of Employees: 12
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange London Stock Exchange (Dual Listing)
Shares in Issue 4,755,407
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AKR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AKR
Upcoming Events for AKR
Frequently Asked Questions for Akers Biosciences Inc
What is the Akers Biosciences Inc share price?

As of 28/03/19, shares in Akers Biosciences Inc are trading at 57.5p, giving the company a market capitalisation of £11.0m. This share price information is delayed by 15 minutes.

How has the Akers Biosciences Inc share price performed this year?

Shares in Akers Biosciences Inc are currently trading at 57.5p and the price has moved by -88.31% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Akers Biosciences Inc price has moved by -86.86% over the past year.

What are the analyst and broker recommendations for Akers Biosciences Inc?

Of the analysts with advisory recommendations for Akers Biosciences Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Akers Biosciences Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Akers Biosciences Inc next release its financial results?

Akers Biosciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Akers Biosciences Inc dividend yield?

Akers Biosciences Inc does not currently pay a dividend.

Does Akers Biosciences Inc pay a dividend?

Akers Biosciences Inc does not currently pay a dividend.

When does Akers Biosciences Inc next pay dividends?

Akers Biosciences Inc does not currently pay a dividend.

How do I buy Akers Biosciences Inc shares?

To buy shares in Akers Biosciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Akers Biosciences Inc?

Shares in Akers Biosciences Inc are currently trading at 57.5p, giving the company a market capitalisation of £11.0m.

Where are Akers Biosciences Inc shares listed? Where are Akers Biosciences Inc shares listed?

Here are the trading details for Akers Biosciences Inc:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: AKR
What kind of share is Akers Biosciences Inc?

We were not able to load our ranking data for Akers Biosciences Inc

Is there a Akers Biosciences Inc share price forecast 2020?

We were not able to load any forecast data for Akers Biosciences Inc.

How can I tell whether the Akers Biosciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Akers Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been -60.09%. At the current price of 57.5p, shares in Akers Biosciences Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Akers Biosciences Inc PE Ratio?

We were not able to find PE ratio data for Akers Biosciences Inc.

Who are the key directors of Akers Biosciences Inc?

Akers Biosciences Inc's management team is headed by:

Howard Yeaton - CEO
Joshua Silverman - LED
Christopher Schreiber - CHM
Bill White - IND
Robert Schroeder - IND
Who are the major shareholders of Akers Biosciences Inc?

Here are the top five shareholders of Akers Biosciences Inc based on the size of their shareholding:

Similar to AKR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.